• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 SPINT1 是胎盘功能不良和胎儿生长受限妊娠的生物标志物。

Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction.

机构信息

Translational Obstetrics Group, The Department of Obstetrics and Gynaecology, Mercy Hospital for Women, University of Melbourne, Heidelberg, 3084, Victoria, Australia.

Mercy Perinatal, Mercy Hospital for Women, Heidelberg, 3084, Victoria, Australia.

出版信息

Nat Commun. 2020 May 15;11(1):2411. doi: 10.1038/s41467-020-16346-x.

DOI:10.1038/s41467-020-16346-x
PMID:32415092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7228948/
Abstract

Placental insufficiency can cause fetal growth restriction and stillbirth. There are no reliable screening tests for placental insufficiency, especially near-term gestation when the risk of stillbirth rises. Here we show a strong association between low circulating plasma serine peptidase inhibitor Kunitz type-1 (SPINT1) concentrations at 36 weeks' gestation and low birthweight, an indicator of placental insufficiency. We generate a 4-tier risk model based on SPINT1 concentrations, where the highest risk tier has approximately a 2-5 fold risk of birthing neonates with birthweights under the 3, 5, 10 and 20 centiles, whereas the lowest risk tier has a 0-0.3 fold risk. Low SPINT1 is associated with antenatal ultrasound and neonatal anthropomorphic indicators of placental insufficiency. We validate the association between low circulating SPINT1 and placental insufficiency in two other cohorts. Low circulating SPINT1 is a marker of placental insufficiency and may identify pregnancies with an elevated risk of stillbirth.

摘要

胎盘功能不全可导致胎儿生长受限和死胎。目前尚无可靠的胎盘功能不全筛查试验,尤其是在妊娠晚期,死胎风险增加。本研究显示,妊娠 36 周时循环血浆丝氨酸蛋白酶抑制剂 Kunitz 型 1(SPINT1)浓度较低与低出生体重(胎盘功能不全的一个指标)密切相关。我们根据 SPINT1 浓度生成了一个 4 级风险模型,其中风险最高的一级出生体重低于第 3、5、10 和 20 百分位的新生儿的风险约为 2-5 倍,而风险最低的一级的风险为 0-0.3 倍。低 SPINT1 与产前超声和新生儿形态学指标均提示胎盘功能不全。我们在另外两个队列中验证了低循环 SPINT1 与胎盘功能不全之间的关联。低循环 SPINT1 是胎盘功能不全的标志物,可能识别出具有死胎风险增加的妊娠。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/54c040b5100e/41467_2020_16346_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/8537c2a79ddf/41467_2020_16346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/4635ac9de062/41467_2020_16346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/5da7df739851/41467_2020_16346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/54c040b5100e/41467_2020_16346_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/8537c2a79ddf/41467_2020_16346_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/4635ac9de062/41467_2020_16346_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/5da7df739851/41467_2020_16346_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e82/7228948/54c040b5100e/41467_2020_16346_Fig4_HTML.jpg

相似文献

1
Circulating SPINT1 is a biomarker of pregnancies with poor placental function and fetal growth restriction.循环 SPINT1 是胎盘功能不良和胎儿生长受限妊娠的生物标志物。
Nat Commun. 2020 May 15;11(1):2411. doi: 10.1038/s41467-020-16346-x.
2
Maternal circulating SPINT1 is reduced in small-for-gestational age pregnancies at 26 weeks: Growing up in Singapore towards health outcomes (GUSTO) cohort study.母体外周血 SPINT1 在 26 孕周的小于胎龄儿妊娠中减少:新加坡朝向健康结局(GUSTO)队列研究。
Placenta. 2021 Jul;110:24-28. doi: 10.1016/j.placenta.2021.05.007. Epub 2021 Jun 1.
3
Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.脑-胎盘-子宫比值作为晚期胎儿生长受限的新型预测指标:前瞻性队列研究。
Ultrasound Obstet Gynecol. 2019 Sep;54(3):367-375. doi: 10.1002/uog.20150.
4
Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight.从中孕期开始生长速度减缓与正常出生体重胎儿的胎盘功能不全有关。
BMC Med. 2020 Dec 24;18(1):395. doi: 10.1186/s12916-020-01869-3.
5
Reduced growth velocity across the third trimester is associated with placental insufficiency in fetuses born at a normal birthweight: a prospective cohort study.孕晚期生长速度减慢与出生体重正常胎儿的胎盘功能不全有关:一项前瞻性队列研究。
BMC Med. 2017 Aug 31;15(1):164. doi: 10.1186/s12916-017-0928-z.
6
Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.胎盘大小与妊娠相关血浆蛋白 A 低值孕妇中严重早发型宫内生长受限的预测
Ultrasound Obstet Gynecol. 2009 Sep;34(3):274-82. doi: 10.1002/uog.7308.
7
Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.在 35-37 孕周的常规超声检查中预测小于胎龄儿和不良围产结局的两阶段方法。
Ultrasound Obstet Gynecol. 2019 Oct;54(4):484-491. doi: 10.1002/uog.20391. Epub 2019 Aug 27.
8
Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.预测小于胎龄儿:孕 35-37 周时通过母体因素、胎儿生物测量和生物标志物进行筛查。
Am J Obstet Gynecol. 2019 May;220(5):486.e1-486.e11. doi: 10.1016/j.ajog.2019.01.227. Epub 2019 Jan 29.
9
Placental pulsatility index: a new, more sensitive parameter for predicting adverse outcome in pregnancies suspected of fetal growth restriction.胎盘搏动指数:预测疑似胎儿生长受限妊娠不良结局的一个新的、更敏感的参数。
Acta Obstet Gynecol Scand. 2017 Feb;96(2):216-222. doi: 10.1111/aogs.13060.
10
Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.在低风险妊娠中,孕30至34周胎盘的超声成熟度与孕中期胎盘功能不全的指标无关。
J Obstet Gynaecol Can. 2010 Dec;32(12):1134-1139. doi: 10.1016/S1701-2163(16)34736-3.

引用本文的文献

1
The association between circulating SIGLEC6 and preeclampsia: observational studies of seven cohorts.循环中唾液酸结合免疫球蛋白样凝集素6(SIGLEC6)与子痫前期的关联:七组队列的观察性研究
EBioMedicine. 2025 Jul 29;118:105870. doi: 10.1016/j.ebiom.2025.105870.
2
Reduced circulating NrCAM as a biomarker for fetal growth restriction.循环中NrCAM减少作为胎儿生长受限的生物标志物。
EBioMedicine. 2025 Jul 21;118:105854. doi: 10.1016/j.ebiom.2025.105854.
3
The human placenta and its role in reproductive outcomes revisited.重新审视人类胎盘及其在生殖结局中的作用。
Physiol Rev. 2025 Oct 1;105(4):2305-2376. doi: 10.1152/physrev.00039.2024. Epub 2025 Jun 11.
4
Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology.使用靶向蛋白质组学Olink技术研究用于筛查胎盘介导的胎儿生长受限疾病的潜在蛋白质生物标志物。
Front Immunol. 2025 May 16;16:1542034. doi: 10.3389/fimmu.2025.1542034. eCollection 2025.
5
The Update of Fetal Growth Restriction Associated with Biomarkers.与生物标志物相关的胎儿生长受限研究进展
Matern Fetal Med. 2022 Jul 22;4(3):210-217. doi: 10.1097/FM9.0000000000000156. eCollection 2022 Jul.
6
Evidence-Based Screening, Diagnosis and Management of Fetal Growth Restriction: Challenges and Confusions.基于证据的胎儿生长受限的筛查、诊断与管理:挑战与困惑
Matern Fetal Med. 2022 Jul 22;4(3):159-161. doi: 10.1097/FM9.0000000000000162. eCollection 2022 Jul.
7
Dynamic changes in peripheral blood CD4+ T cell subsets are associated with litter performance in primiparous gestating sows.初产妊娠母猪外周血CD4 + T细胞亚群的动态变化与产仔性能相关。
J Anim Sci. 2025 Jan 4;103. doi: 10.1093/jas/skaf142.
8
Cystatin 6 (CST6) and Legumain (LGMN) are potential mediators in the pathogenesis of preeclampsia.胱抑素6(CST6)和天冬酰胺内肽酶(LGMN)是子痫前期发病机制中的潜在介质。
Sci Rep. 2025 Apr 15;15(1):12945. doi: 10.1038/s41598-025-96823-9.
9
Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia.早发型子痫前期期间衰老合体滋养层细胞的分泌
Hypertension. 2025 May;82(5):787-799. doi: 10.1161/HYPERTENSIONAHA.124.23362. Epub 2024 Oct 23.
10
MRI assessed placental volume and adverse pregnancy outcomes: Secondary analysis of prospective cohort study.MRI 评估胎盘容积与不良妊娠结局:前瞻性队列研究的二次分析。
Placenta. 2024 Sep 2;154:168-175. doi: 10.1016/j.placenta.2024.07.007. Epub 2024 Jul 14.